Department of Medicine (C5121), University of Manitoba, 409 Tache Avenue, Winnipeg, Manitoba, R2H 2A6, Canada.
Park Nicollet Clinic & HealthPartners Institute, Minneapolis, MN, USA.
Osteoporos Int. 2020 Jun;31(6):1079-1087. doi: 10.1007/s00198-020-05313-3. Epub 2020 Feb 3.
During median follow-up 6.0 years in 11,495 individuals, prior absolute and annualized measured height loss was significantly greater in those with subsequent incident fracture compared with those without incident fracture.
FRAX® accepts baseline height and weight as input variables, but does not consider change in these parameters over time.
To evaluate the association between measured height or weight loss on subsequent fracture risk adjusted for FRAX scores, risk factors, and competing mortality.
Using a dual-energy x-ray absorptiometry (DXA) registry for the Province of Manitoba, Canada, we identified women and men age 40 years or older with height and weight measured at the time of two DXA scans. Cox regression analyses were performed to test for a covariate-adjusted association between prior height and weight loss with incident fractures occurring after the second scan using linked population-based healthcare data.
The study population consisted of 11,495 individuals (average age 68.0 ± 9.9 years, 94.6% women). During median follow-up 6.0 years, records demonstrated incident major osteoporotic fracture (MOF) in 869 individuals, hip fractures in 265, clinical vertebral fractures in 207, and any fracture in 1203. Prior height loss was significantly greater in individuals with fracture compared with those without fracture, regardless of fracture site. Mortality was greater in those with prior height loss (HR per SD 1.11, 95% CI 1.06-1.17) or weight loss (HR per SD 1.26, 95% CI 1.19-1.32). Each SD in height loss was associated with increased fracture risk (MOF 12-17%, hip 8-19%, clinical vertebral 28-37%, any fracture 14-19%). Prior weight loss was associated with 21-30% increased risk for hip fracture, but did not increase risk for other fractures. Height loss of 3.0 cm or greater more than doubled the risk for subsequent fracture.
Prior height loss is associated with a small but significant increase in risk of incident fracture at all skeletal sites independent of other clinical risk factors and competing mortality as considered by FRAX. Prior weight loss only increases risk for subsequent hip fracture.
在 11495 名个体中,中位随访 6.0 年期间,与无骨折事件者相比,后续发生骨折者的既往绝对身高损失和年化身高损失明显更大。
FRAX®接受基线身高和体重作为输入变量,但不考虑这些参数随时间的变化。
评估经 FRAX 评分、危险因素和竞争死亡率校正后的测量身高或体重损失与后续骨折风险之间的关联。
我们利用加拿大马尼托巴省的双能 X 射线吸收法(DXA)登记处,确定了年龄在 40 岁或以上且在两次 DXA 扫描时测量过身高和体重的女性和男性。使用链接的基于人群的医疗保健数据,通过 Cox 回归分析来测试第二次扫描后发生的既往身高和体重损失与后续骨折之间的协变量调整关联。
该研究人群由 11495 名个体组成(平均年龄 68.0±9.9 岁,94.6%为女性)。中位随访 6.0 年期间,记录显示 869 人发生主要骨质疏松性骨折(MOF),265 人发生髋部骨折,207 人发生临床椎体骨折,1203 人发生任何骨折。无论骨折部位如何,与无骨折者相比,骨折者的既往身高损失明显更大。既往身高损失者(每标准差 HR 1.11,95%CI 1.06-1.17)或体重损失者(每标准差 HR 1.26,95%CI 1.19-1.32)的死亡率更高。身高每损失 1 个标准差,骨折风险就会增加(MOF 增加 12%-17%,髋部骨折增加 8%-19%,临床椎体骨折增加 28%-37%,任何骨折增加 14%-19%)。既往体重损失与髋部骨折风险增加 21%-30%相关,但不增加其他骨折的风险。身高损失 3.0cm 或以上使随后骨折的风险增加一倍以上。
既往身高损失与所有骨骼部位的骨折事件风险增加相关,风险虽小但有统计学意义,且独立于 FRAX 所考虑的其他临床危险因素和竞争死亡率。既往体重损失仅增加随后髋部骨折的风险。